Adicet Bio: Building the Next Generation of Cellular Therapies

BY kyrstin
May 2, 2019

Adicet Bio is harnessing the innate allogeneic potential of gamma delta (γδ) T cells to treat solid and liquid tumors. Jeanette Grant, Associate Director of Project Management, discussed the unique challenges in developing these cutting-edge therapeutics, and how Benchling is changing the way Adicet organizes and carries out R&D. Adicet is using Benchling across research teams to power data management and collaboration.

Visit our customer stories page to lean how more companies are powering their life science R&D with Benchling.

You can find information on upcoming Benchling events here, or check out the following posts for more articles and videos of Benchtalk West.

Published by kyrstin

Leave a Reply

%d bloggers like this: